ALXO EPS Estimates
ALX Oncology Holdings Inc.
$0.89
-$0.08(-8.67%)
32
Overall
60
Value
18
Tech
18
Quality
Market Cap
$123.72M
Volume
2.57M
52W Range
$1.05 - $2.66
Target Price
$4.60
ALXO EPS estimates: the consensus estimate for ALX Oncology Holdings Inc.'s current fiscal year is -$0.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ALXO EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.15
- EPS estimate, current year
- $-0.59
- EPS estimate, next year
- $-0.62
- EPS growth, 3-year
- +14.41%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.90 |
| 2024 | $-2.58 |
| 2023 | $-3.74 |
| 2022 | $-3.03 |
| 2021 | $-2.07 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALXO | $0.89 | -8.7% | 2.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ALX Oncology Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW